SEC Form 4 · accession 0001125345-17-000095
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Blasius Risser
Officer — Sr VP & Chief Business Officer
Period of report
Sep 5, 2017
Accepted (ET)
Sep 7, 2017 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 5, 2017 | M | 2,000 | $0.94 | A | 6,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $0.94 | Sep 5, 2017 | M | 2,000 | D | Sep 24, 2009 | Mar 23, 2019 | Common Stock | 2,000 | 31,497 | D |
Explanation of responses
- F1The total reported in Column 9 has been adjusted to correct a prior calculation error in the Form 4 filed by the reporting person on February 8, 2016, which understated the total number of shares.